Antagonistic actions of S-145 ((±)-5(Z)-7-[3-endo[(phenylsulfonyl)aminoJbicyclo[2.2.1]hept-2-exo-yl]heptenoic acid) against U-46619, a thromboxane A
2 mimic, were studied using isolated thoracic aorta of the rat and the trachea, lung parenchyma and ileum of the guinea pig. S-145 as well as SQ-29548 and ONO-3708 inhibited the contraction of aorta induced by U-46619 in a concentration-dependent manner. The IC50 value of each compound was 1.4, 14.5 and 52.6 nM. S-145 also inhibited contractions of the aorta induced by high concentrations of PGE
1, PGE
2 and PGF
2α, but failed to affect the responses to K
+, Ca
2+, NE, 5-HT, and angiotensin II. Contractions of trachea and lung parenchyma of the guinea pig induced by U-46619 were concentration-dependently. inhibited by S-145, but those induced by histamine and leukotriene D
4 were not affected. Ileac contractions by PGE
2 and PGF
2α were not inhibited by S-145. The(+)-isomer of S-145 was more potent and the(-)-isomer was less potent than S-145 for antagonistic action against U-46619. These results suggest that S-145 is a potent and specific antagonist to the thromboxane A
2 receptor; and in the aorta, the thromboxane A
2 receptor may respond to high concentrations of PGs.
View full abstract